* Heartbeam Inc BEAT.OQ BEAT.O is expected to show no
change
in quarterly revenue when it reports results on March 16.
*
* Refinitiv's mean analyst estimate for Heartbeam Inc is
for a
loss of 37 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Heartbeam
Inc is
$10, above its last closing price of $3.15.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 -0.33 -0.32 -0.44 Missed -35.4
Jun. 30 2022 -0.27 -0.43 Missed -59.3
Mar. 31 2022 -0.19 -0.19 -0.27 Missed -42.1
Dec. 31 2021 -0.11
This summary was machine generated March 14 at 20:26 GMT. All
figures in US dollars unless otherwise stated